Responses to E-Cigarette Advertising
Young Adults Responses to E-Cigarette Advertisement Features and the Effect of Restricting Features on Tobacco Use
2 other identifiers
interventional
62
1 country
1
Brief Summary
While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especially alarming because it is not only a critical period in development but also a time when tobacco use is established. Additionally, the tobacco industry targets individuals of this age with the hope that they will one day progress to using combustible cigarettes. Advertising may be one of the reasons leading young people to use ECs, and the Food and Drug Administration (FDA) now has the authority to regulate EC advertisement features. The goal of the study is to determine which EC ad features most strongly influence young adults' attitudes, susceptibility, and intentions to use ECs. Fifteen ads from the most popular EC brands that employ a brand, product descriptions, and modeling features were selected. Young adults who are susceptible to EC use will come into the lab and view these ads. During exposure, they will be assessed for real-time visual attention using eye-tracking, orienting responses using heart rate, and arousal using skin conductance as well as pre- and post-ad self-report measures of attitudes, susceptibility, and behavioral intentions. These factors will help determine the most high impact features, which will be associated with the greatest visual attention, orienting responses, and arousal levels and changes in attitudes. Findings from this study will provide public health officials important and urgently needed information as to what advertising features are contributing to the sharp rise in the use of ECs among young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Aug 2021
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2020
CompletedFirst Posted
Study publicly available on registry
January 30, 2020
CompletedStudy Start
First participant enrolled
August 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2022
CompletedResults Posted
Study results publicly available
September 8, 2023
CompletedSeptember 8, 2023
September 1, 2023
1 year
January 24, 2020
June 29, 2023
September 7, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Attention to Specific ad Feature
Heart rate was measured to assess the cognitive resources allocated to the message. Using three sensors applied to participants' fingers, electrocardiogram (ECG) signals were recorded with a Shimmer 3 EXG module, while viewing the advertisements and were sampled at 512 Hz. Heart change scores were computed using beats per minute (BPM) and subtracting the first second of the stimuli (participant had seen a black screen just prior) from scores for each second of message exposure for each participant. Then, scores were averaged across each advertisement. Lesser values indicated greater deceleration in heart rate, signaling more cognitive resources allocated to the message.
Change from the first second of viewing to each subsequent second of the intervention (10 seconds per ad), averaged for each participant.
Arousal
Skin conductance or galvanic skin response was measured using three sensors applied to participants' fingers. Skin conductance measured if there was an emotional response and the intensity of the emotional response. A "peak" is a biological indicator that something happened, and the participant had an emotional response to it. The amplitude of each peak for each participant was measured and averaged per ad.
The average amplitude of skin conductance peaks over the 10 second viewing window for each ad brand.
Attention to Specific ad Feature
Visual attention was assessed using an eye-tracker connected to the base of the computer screen. For each message, four areas of interest (AOI) were identified: 1) brand, 2) descriptor, 3) modeling, and 4) warning. All four AOIs were summed for a total number of milliseconds that a participant viewed the AOIs.
Duration of seconds spent on all areas of interest during 10 second viewing window for each ad brand
Secondary Outcomes (1)
Motivations to Avoid E-cigarettes
Immediately after viewing each ad
Study Arms (1)
E-Cigarette Ads
EXPERIMENTALAll individuals in the study will see the same e-cigarette advertisements presented in a random order.
Interventions
All participants will see the same e-cigarette ads presented in a random order.
Eligibility Criteria
You may qualify if:
- years old,
- Fluent in English,
- Biochemically confirmed abstinence combusted tobacco or marijuana (eCO: exhaled carbon monoxide \<6 parts per million) at time of visit
- Reporting never trying an e-cigarette, not even a puff OR reporting having used an e-cigarette in the past but has not used in the past 30 days
- Susceptibility to EC use, will be determined using the Susceptibility to Use Tobacco Products questionnaire
You may not qualify if:
- Younger than 18 years or older than 26 years
- Not fluent in English
- Not confirmed abstinent of combusted tobacco or marijuana
- Use of an e-cigarette
- Not susceptible to e-cigarette use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Massachusetts Medical School
Worcester, Massachusetts, 01605, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Elise Stevens
- Organization
- University of Massachusetts Chan Medical School
Study Officials
- PRINCIPAL INVESTIGATOR
Elise M Stevens, PhD
UMass Medical School
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 24, 2020
First Posted
January 30, 2020
Study Start
August 4, 2021
Primary Completion
August 15, 2022
Study Completion
August 15, 2022
Last Updated
September 8, 2023
Results First Posted
September 8, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share